Suppr超能文献

中文版慢性肝病问卷-非酒精性脂肪性肝病在非酒精性脂肪性肝病患者中的可靠性和有效性:中国多中心横断面调查。

Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China.

机构信息

Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, Peking University People's Hospital, Peking University Hepatology Institute, No.11 Xizhimen South Street, Beijing, 100044, China.

Department of Digestive, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Qual Life Res. 2023 Mar;32(3):915-922. doi: 10.1007/s11136-022-03305-w. Epub 2023 Jan 24.

Abstract

PURPOSE

The Chronic Liver Disease Questionnaire (CLDQ)-Nonalcoholic Fatty Liver Disease (NAFLD) is a disease-specific instrument to assess the health-related quality of life (HRQL) of patients with NAFLD. In order to provide further evidence for the cross-cultural utility of this instrument in the Chinese population, we translated the CLDQ-NAFLD into Chinese and examined its reliability and validity.

METHODS

Patients with NAFLD in 90 hospitals across China were enrolled in this multicenter cross-sectional survey. Eligible patients completed the Chinese version of CLDQ-NAFLD at enrollment to assess HRQL. Internal consistency of the questionnaire was assessed using Cronbach's alpha coefficient and split-half reliability. Convergent and discriminant validity were assessed using Spearman correlation coefficient. Factor analysis was used to test the construct validity.

RESULTS

Between March and August 2019, 5181 patients with a mean age of 43.8 ± 13.3 years were enrolled. All domains exhibited good internal consistency, with Cronbach's alpha and split-half reliability greater than 0.70. The scaling success rate of all domains was 100% for convergent validity and 99.4% (179/180) for discriminant validity. The inter-scale correlations indicated a significant correlation between all CLDQ-NAFLD domains (r = 0.608 to 0.832, all p < 0.001). Factor analysis of 36 items extracted 6 factors, which explained 69.14% of the total variance.

CONCLUSION

The Chinese version of CLDQ-NAFLD is a reliable and valid instrument for assessing the HRQL of Chinese patients with NAFLD.

摘要

目的

慢性肝脏疾病问卷(CLDQ)-非酒精性脂肪性肝病(NAFLD)是一种评估 NAFLD 患者健康相关生活质量(HRQL)的特定于疾病的工具。为了提供该工具在中国人中具有跨文化实用性的进一步证据,我们将 CLDQ-NAFLD 翻译成中文,并对其信度和效度进行了评估。

方法

在中国 90 家医院的 NAFLD 患者中开展了这项多中心横断面调查。符合条件的患者在入组时完成了中文版 CLDQ-NAFLD 以评估 HRQL。采用 Cronbach's alpha 系数和半分可靠性评估问卷的内部一致性。采用 Spearman 相关系数评估聚合和判别效度。采用因子分析检验结构效度。

结果

2019 年 3 月至 8 月期间,共纳入 5181 例平均年龄为 43.8±13.3 岁的患者。所有领域的内部一致性均较好,Cronbach's alpha 和半分可靠性均大于 0.70。所有领域的定标成功率在聚合效度方面为 100%(99.4%(179/180)在判别效度方面。各量表间的相关性表明,CLDQ-NAFLD 各领域之间存在显著相关性(r=0.608 至 0.832,均 P<0.001)。36 个项目的因子分析提取了 6 个因子,解释了总方差的 69.14%。

结论

中文版 CLDQ-NAFLD 是一种评估中国 NAFLD 患者 HRQL 的可靠且有效的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验